It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Webinar: Digital Tools for Clinical Trials - Vendor Assessment for Pharma companies

25th August @ 9:00AM EDT

HealthXL and a consortium of representative stakeholders* from across the digital health ecosystem are working to advance the understanding and adoption of digital health products used in clinical trials. To reduce variable implementations of similar quality standards, the group began in Q4 2020 to work towards an open-source industry guidance questionnaire to cover essential operational due diligence. In the intervening six months, this group has convened to create an open-source operational due diligence guidance to facilitate vendor qualification. With a standardized template, vendors will have a response package prepared with the majority of expected documentation in a format that sponsors are ready to accept and review.  While this framework is meant to serve as a guidance for industry, it can easily be adapted to suit individual needs and specifications and can also be adapted for usage in non-clinical trials and other cases. In this webinar, the working group will walk us through:

  • Reason why and objective of the group: what is the gap in the industry we wanted to address?
  • Method: how have we worked to create the answer to the above? 
  • Output overview: Vendor Assessment Checklist for Pharma Companies



The checklist is a Recommendation / Guide / Best-case scenario, non binding. We have excluded clinical evidence generation guidance and in-depth IT system evaluation.

*All the authors participated in this pre-competitive working group as individuals, not representing their company's views on the matter.

Register in advance for this webinar:

https://healthxl.zoom.us/webinar/register/WN_VpQnXNwQRM-G1PUVSAC9aQ

After registering you will receive a confirmation email containing information about joining the webinar.

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Webinar: Digital Tools for Clinical Trials - Vendor Assessment for Pharma companies

Tim Ruckh
Associate Director, Devices and Sensors at AstraZeneca
Philip Russmeyer
Founder & CEO, FITFILE
25th August @ 9:00AM EDT

HealthXL and a consortium of representative stakeholders* from across the digital health ecosystem are working to advance the understanding and adoption of digital health products used in clinical trials. To reduce variable implementations of similar quality standards, the group began in Q4 2020 to work towards an open-source industry guidance questionnaire to cover essential operational due diligence. In the intervening six months, this group has convened to create an open-source operational due diligence guidance to facilitate vendor qualification. With a standardized template, vendors will have a response package prepared with the majority of expected documentation in a format that sponsors are ready to accept and review.  While this framework is meant to serve as a guidance for industry, it can easily be adapted to suit individual needs and specifications and can also be adapted for usage in non-clinical trials and other cases. In this webinar, the working group will walk us through:

  • Reason why and objective of the group: what is the gap in the industry we wanted to address?
  • Method: how have we worked to create the answer to the above? 
  • Output overview: Vendor Assessment Checklist for Pharma Companies



The checklist is a Recommendation / Guide / Best-case scenario, non binding. We have excluded clinical evidence generation guidance and in-depth IT system evaluation.

*All the authors participated in this pre-competitive working group as individuals, not representing their company's views on the matter.

Register in advance for this webinar:

https://healthxl.zoom.us/webinar/register/WN_VpQnXNwQRM-G1PUVSAC9aQ

After registering you will receive a confirmation email containing information about joining the webinar.

You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.


Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.

Join this HealthXL Event today:

Participants

Participants

Tim Ruckh

Associate Director, Devices and Sensors at AstraZeneca

Philip Russmeyer

Founder & CEO, FITFILE

Erwin De beuckelaer

Director Innovative Capabilities, The Janssen Pharmaceutical Companies of Johnson & Johnson

Kris Karson

Strategic Advisor, Phebe Health

Lorcan Walsh

Director, Data Science, Novartis

Shwen Gwee

VP and Head of Global Digital Strategy at Bristol Myers Squibb

JJ Ferrer

Executive Director, Head of Digital Strategy Oncology at Bayer Pharmaceuticals

Rachel Chasse

Director of Innovation at Digital Medicine Society (DiMe)

Looking to connect with digital health gamechangers beyond a meeting? Join the HealthXL Community Hub to connect, learn and discuss:

Join the HealthXL Community Hub
Number of Participants


Up to 12
Date  
August 25, 2021
Community

Webinar: Digital Tools for Clinical Trials - Vendor Assessment for Pharma companies

HealthXL and a consortium of representative stakeholders* from across the digital health ecosystem are working to advance the understanding and adoption of digital health products used in clinical trials. To reduce variable implementations of similar quality standards, the group began in Q4 2020 to work towards an open-source industry guidance questionnaire to cover essential operational due diligence. In the intervening six months, this group has convened to create an open-source operational due diligence guidance to facilitate vendor qualification. With a standardized template, vendors will have a response package prepared with the majority of expected documentation in a format that sponsors are ready to accept and review.  While this framework is meant to serve as a guidance for industry, it can easily be adapted to suit individual needs and specifications and can also be adapted for usage in non-clinical trials and other cases. In this webinar, the working group will walk us through:

  • Reason why and objective of the group: what is the gap in the industry we wanted to address?
  • Method: how have we worked to create the answer to the above? 
  • Output overview: Vendor Assessment Checklist for Pharma Companies



The checklist is a Recommendation / Guide / Best-case scenario, non binding. We have excluded clinical evidence generation guidance and in-depth IT system evaluation.

*All the authors participated in this pre-competitive working group as individuals, not representing their company's views on the matter.

Register in advance for this webinar:

https://healthxl.zoom.us/webinar/register/WN_VpQnXNwQRM-G1PUVSAC9aQ

After registering you will receive a confirmation email containing information about joining the webinar.

Participate in the Meeting

HealthXL Meetings

HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.

Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.

Digital Health Meetings are fully interactive and promote conversation - be ready to talk!

Participant-Led

HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.

Developed for a Busy Schedule

No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.

A Community to connect and network

Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.

continueD learning

Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.

Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Testimonials

Read what our members have to say about our community and meetings:

No items found.
Apply to Attend

Your Digital Health Corner

All Posts
Commentary
September 10, 2021
DTx in Neurology: Status quo and future expectations
DTx in Neurology: Status quo and future expectations
Read More
Commentary
September 10, 2021
Digital Health Vendor Assessment for Clinical Trials
Digital Health Vendor Assessment for Clinical Trials
Read More
Events
September 3, 2021
Fireside Chat with Glen Tullman  | Presented by HealthXL
Fireside Chat with Glen Tullman | Presented by HealthXL
Read More

Frequently Asked Questions

What is a HealthXL Digital Health Meeting?

HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.

read more
view Less

How can I become a member of the Digital Health Community?

We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.

read more
view Less

When can I access the Meeting recording?

Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.

read more
view Less

I am participating in this meeting, but can't attend anymore. Can I cancel it?

It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.

read more
view Less

Webinar: Digital Tools for Clinical Trials - Vendor Assessment for Pharma companies

25th August @ 9:00AM EDT
Clinical Trials Innovation

Webinar: Digital Tools for Clinical Trials - Vendor Assessment for Pharma companies

25th August @ 9:00AM EDT
Clinical Trials Innovation
Tim Ruckh
Associate Director, Devices and Sensors at AstraZeneca
LinkedIn Profile
Philip Russmeyer
Founder & CEO, FITFILE
LinkedIn Profile
Erwin De beuckelaer
Director Innovative Capabilities, The Janssen Pharmaceutical Companies of Johnson & Johnson
LinkedIn Profile
Kris Karson
Strategic Advisor, Phebe Health
LinkedIn Profile
Lorcan Walsh
Director, Data Science, Novartis
LinkedIn Profile
Shwen Gwee
VP and Head of Global Digital Strategy at Bristol Myers Squibb
LinkedIn Profile
JJ Ferrer
Executive Director, Head of Digital Strategy Oncology at Bayer Pharmaceuticals
LinkedIn Profile
Rachel Chasse
Director of Innovation at Digital Medicine Society (DiMe)
LinkedIn Profile

Webinar: Digital Tools for Clinical Trials - Vendor Assessment for Pharma companies

HealthXL and a consortium of representative stakeholders* from across the digital health ecosystem are working to advance the understanding and adoption of digital health products used in clinical trials. To reduce variable implementations of similar quality standards, the group began in Q4 2020 to work towards an open-source industry guidance questionnaire to cover essential operational due diligence. In the intervening six months, this group has convened to create an open-source operational due diligence guidance to facilitate vendor qualification. With a standardized template, vendors will have a response package prepared with the majority of expected documentation in a format that sponsors are ready to accept and review.  While this framework is meant to serve as a guidance for industry, it can easily be adapted to suit individual needs and specifications and can also be adapted for usage in non-clinical trials and other cases. In this webinar, the working group will walk us through:

  • Reason why and objective of the group: what is the gap in the industry we wanted to address?
  • Method: how have we worked to create the answer to the above? 
  • Output overview: Vendor Assessment Checklist for Pharma Companies



The checklist is a Recommendation / Guide / Best-case scenario, non binding. We have excluded clinical evidence generation guidance and in-depth IT system evaluation.

*All the authors participated in this pre-competitive working group as individuals, not representing their company's views on the matter.

Register in advance for this webinar:

https://healthxl.zoom.us/webinar/register/WN_VpQnXNwQRM-G1PUVSAC9aQ

After registering you will receive a confirmation email containing information about joining the webinar.

When:
25th August @ 9:00AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.